Skip to main content

Cresco Labs Inc(CL-CN)
CSE

Today's Change
Delayed Last Update
Day Low1.2600
Day High1.4500
Open:1.2700
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

TOP STORIES: Cresco Labs Inc

Select a category then submit the form to load news
Cresco Labs Delivers Q4 2025 Revenue of $162 Million and Sequential Margin Improvement
Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026
Cresco Labs Establishes At-the-Market Offering
Cresco Labs Opens Sunnyside Tamarac, Expanding Patient Access in Broward County, Florida
Cresco Labs CEO: Rescheduling Marks Historic Shift for Cannabis Industry
Cresco Labs Launches Flagship Flower Brand in Germany
Cresco Labs Delivers Strong Q3, Maintains Market Leadership, and Unlocks New Growth Opportunities
Cresco Labs to Report Third Quarter 2025 Financial Results on November 5, 2025
Cresco Labs Announces Voting Results of Its Annual General and Special Meeting of Shareholders
Cresco Labs Opens Sunnyside Proctorville, Strengthening Ohio Market Leadership
Cresco Labs Closes $325 Million Senior Secured Term Loan Refinancing
Cresco Labs Solid Q2 Performance and Debt Refinancing Strengthen Foundation for Long-Term Value Creation
Cresco Labs Announces Commitments to Refinance its Senior Secured Credit Facility
Cresco Labs Announces Strategic Restructuring and Plans to Divest California Operations
Cresco Labs to Report Second Quarter 2025 Financial Results on August 7, 2025
Cresco Labs Announces Change of Auditor
Cresco Labs Continues Track Record of Delivering Strong Operating Cash Flow
Cresco Labs Announces Updated First Quarter 2025 Earnings Date
Cresco Labs Deepens Core Market Presence with New Sunnyside in Chippewa Township, Beaver Falls, PA
Cresco Labs Announces Rescheduling of First Quarter 2025 Earnings Release and Conference Call
Cresco Labs to Report First Quarter 2025 Financial Results on May 9, 2025
Cresco Labs’ Disciplined Strategy Drives Record Cash Flow in 2024 Financial Results
Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License
Cresco Labs to Report Fourth Quarter 2024 Financial Results on March 12, 2025
Cresco Labs Demonstrates Success of Cash Flow Focused Strategy with Third Quarter 2024 Financial Results
Cresco Labs to Report Third Quarter 2024 Financial Results on November 8, 2024
Cresco Labs Opens Second Sunnyside in Miami, Florida
Cresco Labs Announces Fourth Quarter & Full Year 2022 Results
Cresco Labs Continues Florida Expansion with Two New Store Openings
Cresco Labs Celebrates New Sunnyside Dispensary Opening in South Orlando, Florida
Cresco Labs Reaches 60 Nationwide Dispensaries with the Opening of Two Florida Stores

Profile

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs' national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.